Get Neurostar Tms Therapy System

TMS is more affordable (covered by most insurance and Medicare), and elicits fewer side effects than ECT. It has also been proven to be an effective treatment for depression. However, it appears to be less effective than ECT and requires more sessions.

In the U.S., the benchmark for whether a treatment is cost effective is whether the cost of a QALY comes in at less than $50,000. For TMS, producing one QALY costs $36,000, according to Simpson's analysis. "This is a good deal.

Because of the various factors that influence each person's depression, there's no definitive answer to how long the TMS results will last. Most patients who complete the full course of treatment experience improvement in their symptoms for six months to a year or more.

The treatment itself costs about $200-300 per daily session. That's 3,000-5,000 magnetic pulses over a period of about 20 minutes.

Some of the studies have shown promising but not conclusive evidence for the efficacy of TMS in depression. But TMS has not been shown to be effective in the treatment of obsessive compulsive disorder, posttraumatic disorder, or schizophrenia. The patient sample size has been a cause of concern in most studies.

And, unlike electroconvulsive therapy (ECT), rTMS doesn't cause seizures or require sedation with anesthesia. Generally, rTMS is considered safe and well-tolerated. However, it can cause some side effects.

Most TMS providers find that TMS has a success rate at between 70% or 80%, meaning that the vast majority of individuals find significant relief after treatment. About 50% of people experience complete remission, meaning that the symptoms of depression are absent after just one course of treatment.

About NeuroStar® TMS Therapy NeuroStar uses transcranial magnetic stimulation (TMS) to target key areas of the brain that are underactive in people with depression. It is not ECT (electroconvulsive therapy).